Back to search

Article

A reversible broad-spectrum antiviral targets the human V-ATPase VO domain

2026-06-03

Abstract excerpt

<title>Abstract</title> <p> Increasing threats of viral disease underscore the urgent need for broad-spectrum antiviral drugs (BSADs). Host proteins utilized by human pathogenic viruses are key BSAD targets. The vacuolar-type H⁺-ATPase (V-ATPase) has been identified as a proviral factor for most pH-dependent enveloped viruses classified as pandemic threats. We report here the discovery of cladoniamide A (CA), a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e9032ed-766e-5225-975c-ddd37b4cd5aa
DOI
10.21203/rs.3.rs-9889115/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A reversible broad-spectrum antiviral targets the human V-ATPase VO domainDOI 10.21203/rs.3.rs-9889115/v1
Select a neighboring publication to make it the new centre.